Skip to main content

Find Clinical Trials

Home
Conditions
BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia

Clinical trial condition

BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia trial results

Recruiting

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

NCT07523555

Conditions: BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details